TherapeuticsMD appoints Joseph Ziegler as Principal Financial Officer after resignation of Michael Donegan

TherapeuticsMD, Inc.

Entered Master Services Agreement with JZ Advisory Group for $10,000/month plus 7,500 restricted stock units for Joseph Ziegler as Principal Financial Officer
Michael Donegan resigned as Principal Financial and Accounting Officer effective August 17, 2023
Joseph Ziegler, founder of JZ Advisory Group, succeeded Donegan; previously CFO at DAS Health and Encompass Onsite
Agreement has a three-year term with automatic renewal unless either party provides 30-day non-extension notice

item 1.01 item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Michael C. Donegan

Principal Financial and Accounting Officer

TXMD · TherapeuticsMD, Inc.

Effective: 2023-08-17
Successor: Joseph Ziegler
Filed: August 18, 2023, 7:59 PM ET

On August 17, 2023, Mr. Michael C. Donegan, the Principal Financial and Accounting Officer of the Company, notified the Company of his decision to resign from such positions, effective as of August 17, 2023.

Appointed

Joseph Ziegler

Principal Financial and Accounting Officer

TXMD · TherapeuticsMD, Inc.

Effective: 2023-08-17
Filed: August 18, 2023, 7:59 PM ET

Mr. Ziegler succeeded Mr. Donegan as Principal Financial and Accounting Officer as of the effective date of Mr. Donegan’s resignation.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael C. Donegan resigned as Principal Financial and Accounting Officer at TherapeuticsMD, Inc..

Action: resigned
Role: Principal Financial and Accounting Officer

Exact text from the filing

On August 17, 2023, Mr. Michael C. Donegan, the Principal Financial and Accounting Officer of the Company, notified the Company of his decision to resign from such positions, effective as of August 17, 2023.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Joseph Ziegler was appointed as Principal Financial and Accounting Officer at TherapeuticsMD, Inc..

Action: succeeded
Role: Principal Financial and Accounting Officer

Exact text from the filing

Mr. Ziegler succeeded Mr. Donegan as Principal Financial and Accounting Officer as of the effective date of Mr. Donegan’s resignation.

View on SEC.gov

TherapeuticsMD, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-216056

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.